BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36600099)

  • 1. Head-to-head comparison of [
    Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Lin R; Wang C; Chen S; Lin T; Cai H; Chen S; Yang Y; Zhang J; Xu F; Zhang J; Chen X; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):535-547. PubMed ID: 37728667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study.
    Chen SH; Lin BH; Chen SM; Qiu QR; Ruan ZT; Chen ZJ; Wei Y; Zheng QS; Xue XY; Miao WB; Xu N
    Int Braz J Urol; 2023; 49(6):716-731. PubMed ID: 37624658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of
    Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
    Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.
    Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z
    Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparisons of
    Lin BH; Chen SH; Chen SM; Qiu QR; Gao RC; Wei Y; Zheng QS; Miao WB; Xu N
    Int Urol Nephrol; 2023 Nov; 55(11):2753-2764. PubMed ID: 37477778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary Prostate Cancer : A Pilot Study.
    Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
    Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Qi Z; Yao X; Su M; Huang R
    Hell J Nucl Med; 2023; 26(2):155-156. PubMed ID: 37527052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of [
    Souza SPM; Frasson FC; Takahashi MES; Duarte GBO; Castro VP; Pericole FV; Velloso LA; De Souza CA; Lorand-Metze I; Santos AO; Ramos CD
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2432-2440. PubMed ID: 36988710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
    Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
    Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Trial Assessing the Repeatability and Tumor Uptake of [
    Gondry O; Caveliers V; Xavier C; Raes L; Vanhoeij M; Verfaillie G; Fontaine C; Glorieus K; De Grève J; Joris S; Luyten I; Zwaenepoel K; Vandenbroucke F; Waelput W; Thyparambil S; Vaneycken I; Cousaert J; Bourgeois S; Devoogdt N; Goethals L; Everaert H; De Geeter F; Lahoutte T; Keyaerts M
    J Nucl Med; 2024 Feb; 65(2):178-184. PubMed ID: 38302159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of [
    Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L
    Mol Imaging Biol; 2024 Apr; ():. PubMed ID: 38627276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Lawal IO; Popoola GO; Mahapane J; Kaufmann J; Davis C; Ndlovu H; Maserumule LC; Mokoala KMG; Bouterfa H; Wester HJ; Zeevaart JR; Sathekge MM
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287237
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Xu L; Chen R; Yu X; Liu J; Wang Y
    Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Double Primary Malignant Tumors and their Possible Shared Genes: A Rare Clinical Entity.
    Hu N; Yan G; Tang MW; Wu YH; Xiang YN; Lei PG
    Curr Med Imaging; 2024; 20():e15734056258908. PubMed ID: 38087432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
    Chalikandy A; Yadav S; Basu S
    J Nucl Med Technol; 2023 Dec; 51(4):339-342. PubMed ID: 37586854
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Urso L; Rocca GC; Conti GM; Colella A; Nieri A; Cittanti C; Ippolito C; Bartolomei M
    Nucl Med Mol Imaging; 2023 Dec; 57(6):298-300. PubMed ID: 37982100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [
    Zhi Y; Werner RA; Schirbel A; Higuchi T; Buck AK; Kosmala A; Bley TA; Hagen R; Hackenberg S; Rosenwald A; Scherzad A; Gerhard-Hartmann E; Serfling SE
    Am J Nucl Med Mol Imaging; 2023; 13(5):208-216. PubMed ID: 38023816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68 Ga-LNC-1007 PET/CT Imaging in a Patient With Renal Cell Carcinoma Compared With 68 Ga-PSMA-11 PET/CT.
    Lin R; Wang C; Xu F; Zang J; Miao W
    Clin Nucl Med; 2023 Dec; 48(12):1119-1121. PubMed ID: 37844334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jan; ():. PubMed ID: 38286937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.